Physician profile
Ranette Harrington
NPI 1093407090
$3,068.93
in general payments reported to CMS, 2019-2025
15 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Registered Nurse) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $326 · 2024: $1,393 · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,068.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $600.50 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $573.80 | 2024-2025 | Uzedy, Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $427.36 | 2023-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $228.86 | 2024 | Invega Trinza, Invega Sustenna, Spravato |
| Alkermes, INC. | $228.48 | 2023-2025 | Aristada, Aristada Initio, Lybalvi |
| Supernus Pharmaceuticals, INC. | $214.96 | 2024-2025 | Qelbree |
| Otsuka America Pharmaceutical, INC. | $205.25 | 2023-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Tris Pharma INC | $126.36 | 2023-2024 | Dyanavel Xr |
| Lundbeck LLC | $120.69 | 2024-2025 | Rexulti, Abilify Asimtufii |
| Vanda Pharmaceuticals INC. | $120.17 | 2025 | Fanapt, Hetlioz |
| Corium, LLC | $83.91 | 2023-2024 | Azstarys |
| Neurocrine Biosciences, INC. | $56.72 | 2025 | |
| Vertical Pharmaceuticals, LLC | $29.71 | 2024 | Relexxii |
| Almatica Pharma LLC | $28.29 | 2025 | Loreev Xr |
| Bausch Health US, LLC | $23.87 | 2025 | Wellbutrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranette Harrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.